--- title: "12:09 ET\n\t\t\t\n\t\t\t\n\t\t\t\tINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health" description: "Faruqi & Faruqi, LLP is investigating potential claims against Nutex Health Inc. for alleged violations of federal securities laws. Investors who suffered losses between August 8, 2024, and August 15," type: "news" locale: "en" url: "https://longbridge.com/en/news/256234782.md" published_at: "2025-09-06T16:11:24.000Z" --- # 12:09 ET INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health > Faruqi & Faruqi, LLP is investigating potential claims against Nutex Health Inc. for alleged violations of federal securities laws. Investors who suffered losses between August 8, 2024, and August 15, 2025, are encouraged to contact the firm before the October 21, 2025, deadline to seek lead plaintiff status in a federal securities class action. The investigation follows allegations of misleading statements regarding Nutex's financial practices and a significant drop in stock price after a critical report by Blue Orca Capital. **Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nutex To Contact Him Directly To Discuss Their Options** **If you purchased or acquired securities in Nutex between August 8, 2024 and August 15, 2025** and would like to discuss your legal rights, call Faruqi & Faruqi partner **Josh Wilson directly** at **877-247-4292** or **212-983-9330** **(Ext. 1310)**. **\[You may also click here for additional information\]** , /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX) and reminds investors of the **October 21, 2025 deadline** to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) HaloMD was achieving lucrative arbitration results for Nutex by engaging in a coordinated scheme to defraud insurance companies; (2) as a result, to the extent that they were the product of fraudulent conduct, revenues attributable to the Company's engagement with HaloMD in the IDR process were unsustainable; (3) in addition, the Company overstated the extent to which it had remediated, and/or its ability to remediate, the material weaknesses in its internal controls over financial reporting; (4) as a result, the Company was unable to effectively account for the treatment of certain of its stock based compensation obligations; (5) as a result, Nutex improperly calculated these stock based compensation obligations as equity rather than liabilities; (6) the foregoing increased the risk that the Company would be unable to timely file certain financial reports with the United States Securities and Exchange Commission ("SEC"); (7) accordingly, Nutex's business and/or financial prospects were overstated; and (8) as a result, Defendants' public statements were materially false and misleading at all relevant times. On July 22, 2025, Blue Orca Capital ("Blue Orca") issued a short report on Nutex. The Blue Orca report alleges, among other things, that Nutex faces litigation risk due to its relationship with HaloMD, a third-party vendor that was recently sued for engaging in a "coordinated fraudulent scheme" to take millions from insurance companies on behalf of healthcare billing clients. Following publication of the Blue Orca report, Nutex's stock price fell $11.18 per share, or 10.05%, to close at $100.01 per share on July 22, 2025. On July 24, 2025, Nutex issued a press release responding to the Blue Orca Report, stating that it "strongly disagrees with the allegations in the report" and that it "expects to provide related updates in its upcoming earnings release and Form 10-Q for the second quarter of 2025 due on or before August 14, 2025." However, after the market closed on August 14, 2025, Nutex announced that it would "delay filing its Form 10-Q for the period ending June 30, 2025", citing "non-cash accounting adjustments related to the treatment of stock-based compensation obligations for certain under-construction and ramping hospitals, as disclosed in previous filings." When Nutex failed to rebut the allegations of the Blue Orca Report, the Company's stock price fell $18.22 per share, or 16.39%, to close at $92.91 per share on August 15, 2025. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding Nutex's conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the **Nutex Health** class action, go to **www.faruqilaw.com/NUTX** or **call** Faruqi & Faruqi partner **Josh Wilson directly** at **877-247-4292** or **212-983-9330** **(Ext. 1310)**. Follow us for updates on LinkedIn, on X, or on Facebook. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner. SOURCE Faruqi & Faruqi, LLP ### Related Stocks - [NUTX.US - Nutex Health](https://longbridge.com/en/quote/NUTX.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | SDM 股東行動提醒：Faruqi & Faruqi, LLP 提醒 Smart Digital (SDM) 投資者證券集體訴訟的截止日期為2026年3月16日 | Faruqi & Faruqi, LLP 提醒 Smart Digital (SDM) 的投資者注意，2026 年 3 月 16 日是尋求在聯邦證券集體訴訟中擔任主原告的截止日期。該公司正在調查針對 Smart Digital 的指控，涉及 | [Link](https://longbridge.com/en/news/275624796.md) | | 美國決定應從 1260h 節中移除 12 家公司，其中包括長江存儲，這一決定已在聯邦公報中公佈 | 美國決定將包括 YMTX 在內的 12 家公司從第 1260h 節中移除，相關信息已在聯邦公報中發佈 | [Link](https://longbridge.com/en/news/275913233.md) | | Didlake 公司任命 Maria Clara De Araujo 為合同運營副總裁 | Didlake 任命瑪麗亞·克拉拉·德阿勞霍為合同運營副總裁。她在聯邦合同和運營管理方面擁有超過十年的經驗，將提升合同績效和客户參與度。首席執行官保羅·格拉夫利強調了她的專業知識和對 Didlake 使命的承諾，即通過為殘疾人士提供就業機會 | [Link](https://longbridge.com/en/news/275923304.md) | | 10:01 ETFedstack，作為 Smoothstack 旗下公司，增強了聯邦交付能力和勞動力領導力 | Fedstack，Smoothstack, Inc. 的聯邦技術和勞動力解決方案部門，已任命 Kevin Bierschenk 為高級副總裁，Rebecca Bier 為客户解決方案副總裁。這些任命旨在增強 Fedstack 對聯邦執行和勞 | [Link](https://longbridge.com/en/news/275626145.md) | | 律師 SEO 有限責任公司成功註冊了 LAWSEO®的聯邦商標 | 律師搜索引擎優化公司（SEO for Lawyers, LLC）已獲得聯邦商標註冊，註冊商標為 LAWSEO®，確認其在法律搜索引擎優化領域的獨佔所有權和市場領導地位。美國專利商標局於 2026 年 2 月 3 日頒發了註冊號 8,130, | [Link](https://longbridge.com/en/news/275794622.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.